APA (7th ed.) Citation

Yu, H. J., Fuller, D., Anand, R., Fuller, T., Munoz, J., Moore, C., . . . Schefler, A. C. (2022). Two-year results for ranibizumab for radiation retinopathy (RRR): A randomized, prospective trial. Graefe's archive for clinical and experimental ophthalmology, 260(1), 47-54. https://doi.org/10.1007/s00417-021-05281-2

Chicago Style (17th ed.) Citation

Yu, Hannah J., Dwain Fuller, Rajiv Anand, Timothy Fuller, Jose Munoz, Chelsey Moore, Ryan S. Kim, and Amy C. Schefler. "Two-year Results for Ranibizumab for Radiation Retinopathy (RRR): A Randomized, Prospective Trial." Graefe's Archive for Clinical and Experimental Ophthalmology 260, no. 1 (2022): 47-54. https://doi.org/10.1007/s00417-021-05281-2.

MLA (9th ed.) Citation

Yu, Hannah J., et al. "Two-year Results for Ranibizumab for Radiation Retinopathy (RRR): A Randomized, Prospective Trial." Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 260, no. 1, 2022, pp. 47-54, https://doi.org/10.1007/s00417-021-05281-2.